Canada markets open in 5 hours 1 minute

  • S&P/TSX

    19,791.62
    -423.07 (-2.09%)
     

  • S&P 500

    4,330.00
    -72.20 (-1.64%)
     

  • DOW

    34,070.42
    -370.46 (-1.08%)
     

  • CAD/USD

    0.7424
    +0.0005 (+0.07%)
     

  • CRUDE OIL

    89.91
    +0.28 (+0.31%)
     

  • Bitcoin CAD

    35,938.07
    -399.13 (-1.10%)
     

  • CMC Crypto 200

    568.80
    -7.45 (-1.29%)
     

  • GOLD FUTURES

    1,946.80
    +7.20 (+0.37%)
     

  • RUSSELL 2000

    1,781.83
    -28.28 (-1.56%)
     

  • 10-Yr Bond

    4.4800
    0.0000 (0.00%)
     

  • NASDAQ futures

    14,922.75
    +60.00 (+0.40%)
     

  • VOLATILITY

    17.28
    -0.26 (-1.48%)
     

  • FTSE

    7,681.82
    +3.20 (+0.04%)
     

  • NIKKEI 225

    32,402.41
    -168.62 (-0.52%)
     

  • CAD/EUR

    0.6973
    +0.0016 (+0.23%)
     

Why Shares of Bellus Health Skyrocketed This Week

Jim Halley, The Motley Fool
·2 min read
Why Shares of Bellus Health Skyrocketed This Week

Shares of Bellus Health (NASDAQ: BLU) jumped 105.1% this week as of Thursday afternoon, according to data provided by S&P Global Market Intelligence. The company, which received a $2 billion buyout offer from GSK (formerly known as GlaxoSmithKline) (NYSE: GSK), closed at $7.06 last week and reached a new 52-week high at $14.50 on Tuesday. The attraction for GSK is camlipixant, Bellus' late-stage pipeline candidate to treat adults with refractory chronic cough (RCC).

Continue reading